A dive into gonorrhoea’s past
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20243879Keywords:
Gonorrhoea, Nucleic acid amplification test, The clapAbstract
Gonorrhoea has a long-standing presence in human history, being recognized as one of the earliest sexually transmitted infections (STIs). While its exact origins are debated, there are references to a disease resembling gonorrhoea in ancient texts. The Chinese emperor Huang Ti mentioned a condition similar to gonorrhoea in his medical writings around 2600 BC. Additionally, some interpret passages in the book of Leviticus in the Old Testament as descriptions and precautions for gonorrhoea. Gonorrhoea, one of the oldest known STIs, has undergone significant changes in diagnosis and management over the centuries. Despite periods of decline, there has been a resurgence of the infection in recent decades. The emergence of drug-resistant strains and risky sexual behaviour may have contributed to this resurgence. To combat the spread of gonorrhoea, it's crucial to promote safe sex practices and provide comprehensive sex education, especially among teenagers. Timely adjustments to treatment regimens to address drug-resistant strains are also essential. By taking these steps, we can work towards reducing the prevalence and impact of gonorrhoea globally.
Metrics
References
Centers for Disease Control and Prevention. Recommended treatment schedules for gonorrhoea-March 1972. MMWR. 1972;21:82.
US Department of Health and Human Services. Sexually transmitted diseases treatment guidelines 1982. MMWR. 1982;31(2):35S-60S.
Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2015. Atlanta, GA: Department of Health and Human Services. 2015.
Herrell WE, Cook EN, Thompson L. Use of penicillin for sulfonamide resistant gonorrheal infections. JAMA. 1943;122(5):289-92. DOI: https://doi.org/10.1001/jama.1943.02840220021005
Miller CP, Scott WW, Moeller V. Studies on the action of penicillin. 1. The rapidity of its therapeutic effect on gonococcic urethritis. JAMA. 1944;125(9):607-10. DOI: https://doi.org/10.1001/jama.1944.02850270005002
Mahoney JF, Ferguson C, Buchholtz M, Van Slyke CI. The use of penicillin sodium in the treatment of sulfonamide resistant gonorrhea in men: a preliminary report. Am J Syphilis. 1943;27:525-8.
Brandt AM. No magic bullet: a social history of venereal disease in the United States since 1880. New York, NY. Oxford University Press. 1985.
Thayer JD, Moore MB. Gonorrhea: Present knowledge, research and control efforts. Med Clin North Am. 1964;48:755-65. DOI: https://doi.org/10.1016/S0025-7125(16)33456-3
Kjellander JO, Finland M. Penicillin treatment of gonorrheal urethritis. N Engl J Med. 1963;269:834-6. DOI: https://doi.org/10.1056/NEJM196310172691603
Martin JE Jr, Lester A, Price EV, Schmale JD. Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969. J Infect Dis. 1970;122:459-61. DOI: https://doi.org/10.1093/infdis/122.5.459
Olsen GA, Lomholt G. Gonorrhoea treated by a combination of probenecid and sodium penicillin G. Br J Vener Dis. 1969;45:144-8. DOI: https://doi.org/10.1136/sti.45.2.144
Cornelius CE 3rd, Schroeter AL, Lester A, Martin JE Jr. Variations in serum concentrations of penicillin after injections of aqueous procaine penicillin G with and without oral probenecid. Br J Vener Dis. 1971;47:359-63. DOI: https://doi.org/10.1136/sti.47.5.359
Holmes KK, Karney WW, Harnisch JP, Wiesner PJ, Turck M, Pedersen AH. Single-dose aqueous procaine penicillin G therapy for gonorrhea: use of probenecid and cause of treatment failure. J Infect Dis. 1973;127:455-60. DOI: https://doi.org/10.1093/infdis/127.4.455
Green RL, Lewis JE, Kraus SJ, Frederickson EL. Elevated plasma procaine concentrations after administration of procaine penicillin G. N Engl J Med. 1974;291:223-6. DOI: https://doi.org/10.1056/NEJM197408012910503
Amies CE. Development of resistance of gonococci to penicillin: an eight year study. Can Med Assoc J. 1967;96:33-5.
Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neisseria gonorrhoeae. Lancet. 1976;2:657-8. DOI: https://doi.org/10.1016/S0140-6736(76)92467-3
Jaffe HW, Biddle JW, Johnson SR, Wiesner PJ. Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis. 1981;144:191-7. DOI: https://doi.org/10.1093/infdis/144.2.191
Sparling PF. Antibiotic resistance in the gonococcus. In: Roberts RB, ed. The gonococcus. New York, NY: John Wiley and Sons. 1977;112-35.
Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587-613. DOI: https://doi.org/10.1128/CMR.00010-14
Kaufman RE, Johnson RE, Jaffe HW, Thornsberry C, Reynolds GH, Wiesner PJ. National Gonorrhea Therapy Monitoring Study: treatment results. N Engl J Med. 1976;294:1-4. DOI: https://doi.org/10.1056/NEJM197601012940101
Tiedemann JH, Hackney JF, Price EV. Acute gonorrheal urethritis in men. treatment with spectinomycin sulfate. JAMA. 1965;191:89-91. DOI: https://doi.org/10.1001/jama.1965.03080020017005
Sparling PF, Yobs AR, Billings TE, Hackney JF. Spectinomycin sulfate and aqueous procaine penicillin G in treatment of female gonorrhea. Antimicrob Agents Chemother (Bethesda). 1965;5:68992.
Pedersen AH, Wiesner PJ, Holmes KK, Johnson CJ, Turck M. Spectinomycin and penicillin G in the treatment of gonorrhea: a comparative evaluation. JAMA. 1972;220:205-8. DOI: https://doi.org/10.1001/jama.220.2.205
Wiesner PJ, Tronca E, Bonin P, Pedersen AH, Holmes KK. Clinical spectrum of pharyngeal gonococcal infection. N Engl J Med. 1973;288:181-5. DOI: https://doi.org/10.1056/NEJM197301252880404
Centers for Disease Control and Prevention. Notice to readers: shortage of spectinomycin. MMWR. 2001;50:470.
Boslego JW, Tramont EC, Takafuji ET. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1987;317:272-8. DOI: https://doi.org/10.1056/NEJM198707303170504
Romanowski B, Wood H, Draker J, Tsianco MC. Norfloxacin in the therapy of uncomplicated gonorrhea. Antimicrob Agents Chemother. 1986;30:514-5. DOI: https://doi.org/10.1128/AAC.30.3.514
Crider SR, Colby SD, Miller LK, Harrison WO, Kerbs SB, Berg SW. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. N Engl J Med. 1984;311:137-40. DOI: https://doi.org/10.1056/NEJM198407193110301
Roddy RE, Handsfield HH, Hook EW 3rd. Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men. Antimicrob Agents Chemother. 1986;30:267-9. DOI: https://doi.org/10.1128/AAC.30.2.267
Rajakumar MK, Ngeow YF, Khor BS, Lim KF. Ofloxacin, a new quinolone for the treatment of gonorrhea. Sex Transm Dis. 1988;15:25-6. DOI: https://doi.org/10.1097/00007435-198801000-00005
Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR. 1998;47:1-116.
Centers for Disease Control and Prevention. Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332-6.
Yoshikawa TT, Shibata SA, Herbert P, Oill PA. In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae. Antimicrob Agents Chemother. 1980;18:355-6. DOI: https://doi.org/10.1128/AAC.18.2.355
Rajan VS, Sng EH, Thirumoorthy T, Goh CL. Ceftriaxone in the treatment of ordinary and penicillinase-producing strains of Neisseria gonorrhoeae. Br J Vener Dis. 1982;58:314-6. DOI: https://doi.org/10.1136/sti.58.5.314
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. 1985. MMWR Morb Mortal Wkly Rep. 1985;31(1):33s-62.
WHO Expert Committee on Venereal Diseases and Treponematoses, 6th report. Technical Report Series 736. Geneva, Switzerland: World Health Organization. 1986. Available at: https://iris.who.int/bitstream/handle/10665/39675/WHO_TRS_736.pdf?sequence=1&isAllowed=y. Accessed on 3 November 2024.
Rodgers S, Murgatroyd M, Perez K, Kingston M, Lee V. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea. Int J STD AIDS. 2014;25(2):145-7. DOI: https://doi.org/10.1177/0956462413495822
Downloads
Published
How to Cite
Issue
Section
